ScieHome
Latest round
- Series A
Last raised
- May 2026
Total raised
- Undisclosed
Investors
- 1
About ScieHome
, trading as ScieHome, is a medical device company dedicated to creating a platform of scientific and technological innovation centered around interventional ultrasound and drug-device combination technologies. The founding team of the company has experience in ultrasound energy R&D, drug-device technology synergy and so on, with over 10 years of executive positions and work experience at companies such as MicroPort Medical and Philips Medical. It's founder, Mr. Wu Changsheng, is a former project leader for the Firehawk drug-eluting stent system at MicroPort Medical. The company focuses on the development and provision of innovative energy device products that solve clinical challenges. It has established a series of technological platforms, including interventional ultrasound energy technology, drug-device combination technology, software and algorithm architecture technology, etc. Its first core product, the SciHonic ultrasound-assisted thrombolysis system, is based on multidisciplinary underlying technology accumulation and is designed to closely align with clinical scenarios, currently in the registration clinical stage. The company generates revenue by developing and commercializing interventional ultrasound medical devices and integrated therapeutic solutions.
Who invested in ScieHome
1 investor across 1 round
See all investors in ScieHome
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 21, 2026
Amount
Undisclosed
Investors
Questions about ScieHome
Who invested in ScieHome?
ScieHome has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ScieHome raised?
ScieHome has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did ScieHome last raise money?
ScieHome's most recent round on record is a Series A, in May 2026.
What does ScieHome do?
, trading as ScieHome, is a medical device company dedicated to creating a platform of scientific and technological innovation centered around interventional ultrasound and drug-device combination technologies.
Where is ScieHome headquartered?
ScieHome is headquartered in Shanghai, China.
Which VCs invest in companies like ScieHome?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at ScieHome's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like ScieHome? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.